Gross margin moved 5063 bp lower
Gross margin changed -5063 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes.
69.21%→18.58%5 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →XTIA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed across a low base
Revenue changed +5622.3% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
$484,000→$27.7M5 prior comparisons
Free-cash-flow proxy increased 30.8%
Free-cash-flow proxy changed +30.8% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
-$15.3M→-$10.6M7 prior comparisons
Operating cash flow increased 31.4%
Operating cash flow changed +31.4% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
-$15.2M→-$10.5M7 prior comparisons
Gross profit changed across a low base
Gross profit changed +1436.1% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
$335,000→$5.1M5 prior comparisons
Net income decreased 174.0%
Net income changed -174.0% from the comparable as-filed period.
-$12.9M→-$35.3M3 prior comparisons
Operating margin moved 211166 bp higher
Operating margin changed +211166 basis points from the comparable as-filed period.
-2149.17%→-37.51%3 prior comparisons
Cash & equivalents increased 89.6%
Cash & equivalents changed +89.6% from the comparable as-filed period.
$8.0M→$15.2M2 prior comparisons
Research & development decreased 30.2%
Research & development changed -30.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
$1.7M→$1.2M4 prior comparisons
Capex / revenue moved 882 bp lower
Capex / revenue changed -882 basis points from the comparable as-filed period.
9.30%→0.47%2 prior comparisons
Inventory increased 737.5%
Inventory changed +737.5% from the comparable as-filed period.
$2.3M→$19.4M3 prior comparisons
Inventory / revenue moved 40883 bp lower
Inventory / revenue changed -40883 basis points from the comparable as-filed period.
478.93%→70.09%3 prior comparisons
SBC / revenue moved 7651 bp lower
SBC / revenue changed -7651 basis points from the comparable as-filed period.
94.01%→17.50%2 prior comparisons
Capital expenditure increased 191.1%
Capital expenditure changed +191.1% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
$45,000→$131,0006 prior comparisons
Stock-based compensation changed across a low base
Stock-based compensation changed +965.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$455,000→$4.8M3 prior comparisons
Operating income increased 0.1%
Operating income changed +0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
-$10.4M→-$10.4M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.